… -M types of β-lactamases in clinical isolates of E. coli and K. pneumoniae producing ESBLs.
… of MBLs, AmpC and CTX-M types of β-lactamases among clinical isolates of E. coli and K. …

… Prevalence of NDM-producing Klebsiella pneumoniae among clinical isolates worldwide. …
and genotype distribution of human clinical isolates of NPKP based on published studies.. …

… relative resistance to beta-lactams (3, 7), have been notable in some reports (1, 9, 10). To
identify any trend toward increasing antibiotic resistance among clinical isolates of E. faecium, …

… clinical isolates ofKlebsiella pneumoniae from southern Taiwan were found to produce
extended-spectrum β-lactamases … 3 produced a novel AmpC β-lactamase designated CMY-8 with …

… Bacterial isolates Strains investigated in this study were 103 non-replicate clinical isolates
of Enterobacteriaceae producing a complex β-lactamase pattern including a TEM-type or an …

… β-lactamases (ie, AmpC β-lactamases and metallo-β-lactamases) and acquired extended-spectrum
β-lactamases … clinical implications of the complexity of β-lactamases are discussed. …

… in clinical isolates recovered from hospitalized patients (36). In our study, as only two
isolates harbored AmpC-β-lactamase, it … These results indicate that AmpC-β-lactamase-producing …

… The results in the present study showed that screening should include all the clinical
isolates showing resistance to any of the cephalosporins and/or aztreonam, irrespective of their …

… We identified 2 clinical isolates of E. coli that produced the plasmid-… 2 clinical isolates of
E. coli that produced plasmid-mediated AmpC enzymes, and we report their associated clinical …

… in clinical development for the treatment of infections caused by carbapenem-resistant and
difficult-to-treat resistant (DTR) (defined as resistance to all tested β-lactams … clinical isolates …